{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:16:02Z","timestamp":1792790162893,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"JSPS KAKENHI","award":["15K10854"],"award-info":[{"award-number":["15K10854"]}]},{"name":"JSPS KAKENHI","award":["20H03839"],"award-info":[{"award-number":["20H03839"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study investigated the effects of omidenepag (OMD), a novel selective EP2 receptor agonist, on human trabecular meshwork (HTM) cells, monkey Schlemm\u2019s canal endothelial (SCE) cells, and porcine ciliary muscle (CM) to clarify the mechanism of intraocular pressure (IOP) reduction involving conventional outflow pathway. In HTM and SCE cells, the effects of OMD on transforming growth factor-\u03b22 (TGF-\u03b22)-induced changes were examined. The expression of actin cytoskeleton and extracellular matrix (ECM) proteins, myosin light chain (MLC) phosphorylation in HTM cells were evaluated using real-time quantitative PCR, immunocytochemistry, and western blotting. The expression of barrier-related proteins, ZO-1 and \u03b2-catenin, and permeability of SCE cells were evaluated using immunocytochemistry and transendothelial electrical resistance. The CM contraction was determined by contractibility assay. OMD significantly inhibited expression of TGF-\u03b22 induced mRNA, protein, and MLC-phosphorylation on cytoskeletal and ECM remodeling in the HTM dose dependently. In SCE cells, OMD suppressed TGF-\u03b22-induced expression of the barrier-related proteins and decreased SCE monolayer permeability. OMD at 3\u00a0\u00b5M significantly inhibited CM contraction, however, the effect was not significant at lower concentrations. IOP lowering effect of OMD through conventional outflow pathway is exerted by increasing outflow facilities with the modulation of TM cell fibrosis and SCE cell permeability.<\/jats:p>","DOI":"10.1038\/s41598-021-95768-z","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T10:03:10Z","timestamp":1628589790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Effects of selective EP2 receptor agonist, omidenepag, on trabecular meshwork cells, Schlemm\u2019s canal endothelial cells and ciliary muscle contraction"],"prefix":"10.1038","volume":"11","author":[{"given":"Natsuko","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Honjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"key":"95768_CR1","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/s0140-6736(04)16257-0","volume":"363","author":"RN Weinreb","year":"2004","unstructured":"Weinreb, R. N. & Khaw, P. T. Primary open-angle glaucoma. Lancet 363, 1711\u20131720. https:\/\/doi.org\/10.1016\/s0140-6736(04)16257-0 (2004).","journal-title":"Lancet"},{"key":"95768_CR2","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb, R. N., Aung, T. & Medeiros, F. A. The pathophysiology and treatment of glaucoma: A review. JAMA 311, 1901\u20131911. https:\/\/doi.org\/10.1001\/jama.2014.3192 (2014).","journal-title":"JAMA"},{"key":"95768_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/s1350-9462(99)00015-4","volume":"19","author":"M Wiederholt","year":"2000","unstructured":"Wiederholt, M., Thieme, H. & Stumpff, F. The regulation of trabecular meshwork and ciliary muscle contractility. Prog. Retin. Eye Res. 19, 271\u2013295. https:\/\/doi.org\/10.1016\/s1350-9462(99)00015-4 (2000).","journal-title":"Prog. Retin. Eye Res."},{"key":"95768_CR4","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.exer.2005.10.011","volume":"82","author":"M Johnson","year":"2006","unstructured":"Johnson, M. What controls aqueous humour outflow resistance?. Exp. Eye Res. 82, 545\u2013557. https:\/\/doi.org\/10.1016\/j.exer.2005.10.011 (2006).","journal-title":"Exp. Eye Res."},{"key":"95768_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0047-6374(89)90017-1","volume":"47","author":"MA Babizhayev","year":"1989","unstructured":"Babizhayev, M. A. & Brodskaya, M. W. Fibronectin detection in drainage outflow system of human eyes in ageing and progression of open-angle glaucoma. Mech. Ageing Dev. 47, 145\u2013157. https:\/\/doi.org\/10.1016\/0047-6374(89)90017-1 (1989).","journal-title":"Mech. Ageing Dev."},{"key":"95768_CR6","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.exer.2009.01.008","volume":"88","author":"B Junglas","year":"2009","unstructured":"Junglas, B., Yu, A. H., Welge-L\u00fcssen, U., Tamm, E. R. & Fuchshofer, R. Connective tissue growth factor induces extracellular matrix deposition in human trabecular meshwork cells. Exp. Eye Res. 88, 1065\u20131075. https:\/\/doi.org\/10.1016\/j.exer.2009.01.008 (2009).","journal-title":"Exp. Eye Res."},{"key":"95768_CR7","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.exer.2008.11.033","volume":"88","author":"DR Overby","year":"2009","unstructured":"Overby, D. R., Stamer, W. D. & Johnson, M. The changing paradigm of outflow resistance generation: Towards synergistic models of the JCT and inner wall endothelium. Exp. Eye Res. 88, 656\u2013670. https:\/\/doi.org\/10.1016\/j.exer.2008.11.033 (2009).","journal-title":"Exp. Eye Res."},{"key":"95768_CR8","doi-asserted-by":"publisher","unstructured":"Acott, T. S., Vranka, J. A., Keller, K. E., Raghunathan, V. & Kelley, M. J. Normal and glaucomatous outflow regulation. Prog. Retin. Eye Res. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100897 (2020).","DOI":"10.1016\/j.preteyeres.2020.100897"},{"key":"95768_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1006\/exer.1994.1158","volume":"59","author":"RC Tripathi","year":"1994","unstructured":"Tripathi, R. C., Li, J., Chan, W. F. & Tripathi, B. J. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp. Eye Res. 59, 723\u2013727. https:\/\/doi.org\/10.1006\/exer.1994.1158 (1994).","journal-title":"Exp. Eye Res."},{"key":"95768_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s004170000241","volume":"239","author":"M Inatani","year":"2001","unstructured":"Inatani, M. et al. Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefes Arch. Clin. Exp. Ophthalmol. 239, 109\u2013113. https:\/\/doi.org\/10.1007\/s004170000241 (2001).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"95768_CR11","doi-asserted-by":"publisher","first-page":"P112","DOI":"10.1016\/j.ophtha.2015.10.055","volume":"123","author":"BE Prum Jr","year":"2016","unstructured":"Prum, B. E. Jr. et al. Primary open-angle glaucoma suspect preferred practice pattern(\u00ae) guidelines. Ophthalmology 123, P112-151. https:\/\/doi.org\/10.1016\/j.ophtha.2015.10.055 (2016).","journal-title":"Ophthalmology"},{"key":"95768_CR12","doi-asserted-by":"publisher","unstructured":"European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition-Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options. Br. J. Ophthalmol. 101, 130\u2013195. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-EGSguideline.003 (2017).","DOI":"10.1136\/bjophthalmol-2016-EGSguideline.003"},{"key":"95768_CR13","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/0014-4835(88)90043-7","volume":"47","author":"E L\u00fctjen-Drecoll","year":"1988","unstructured":"L\u00fctjen-Drecoll, E. & Tamm, E. Morphological study of the anterior segment of cynomolgus monkey eyes following treatment with prostaglandin F2 alpha. Exp. Eye Res. 47, 761\u2013769. https:\/\/doi.org\/10.1016\/0014-4835(88)90043-7 (1988).","journal-title":"Exp. Eye Res."},{"key":"95768_CR14","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.1167\/iovs.02-1281","volume":"44","author":"M Richter","year":"2003","unstructured":"Richter, M., Krauss, A. H., Woodward, D. F. & L\u00fctjen-Drecoll, E. Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide. Invest. Ophthalmol. Vis. Sci. 44, 4419\u20134426. https:\/\/doi.org\/10.1167\/iovs.02-1281 (2003).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95768_CR15","first-page":"2772","volume":"38","author":"RN Weinreb","year":"1997","unstructured":"Weinreb, R. N., Kashiwagi, K., Kashiwagi, F., Tsukahara, S. & Lindsey, J. D. Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest. Ophthalmol. Vis. Sci. 38, 2772\u20132780 (1997).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95768_CR16","first-page":"3705","volume":"43","author":"TL Anthony","year":"2002","unstructured":"Anthony, T. L., Lindsey, J. D. & Weinreb, R. N. Latanoprost\u2019s effects on TIMP-1 and TIMP-2 expression in human ciliary muscle cells. Invest. Ophthalmol. Vis. Sci. 43, 3705\u20133711 (2002).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95768_CR17","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1167\/iovs.05-0516","volume":"47","author":"DJ Oh","year":"2006","unstructured":"Oh, D. J. et al. Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost. Invest. Ophthalmol. Vis. Sci. 47, 953\u2013963. https:\/\/doi.org\/10.1167\/iovs.05-0516 (2006).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95768_CR18","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.1167\/iovs.08-3356","volume":"50","author":"YH Ooi","year":"2009","unstructured":"Ooi, Y. H., Oh, D. J. & Rhee, D. J. Effect of bimatoprost, latanoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human ciliary body smooth muscle cells. Invest. Ophthalmol. Vis. Sci. 50, 5259\u20135265. https:\/\/doi.org\/10.1167\/iovs.08-3356 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95768_CR19","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/eye.2012.195","volume":"26","author":"K Inoue","year":"2012","unstructured":"Inoue, K. et al. Adverse periocular reactions to five types of prostaglandin analogs. Eye (Lond.) 26, 1465\u20131472. https:\/\/doi.org\/10.1038\/eye.2012.195 (2012).","journal-title":"Eye (Lond.)"},{"key":"95768_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1167\/iovs.17-22745","volume":"59","author":"T Kirihara","year":"2018","unstructured":"Kirihara, T. et al. Pharmacologic characterization of omidenepag isopropyl, a novel selective EP2 receptor agonist, as an ocular hypotensive agent. Invest. Ophthalmol. Vis. Sci. 59, 145\u2013153. https:\/\/doi.org\/10.1167\/iovs.17-22745 (2018).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95768_CR21","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1089\/jop.2019.0044","volume":"35","author":"M Aihara","year":"2019","unstructured":"Aihara, M. et al. Pharmacokinetics, safety, and intraocular pressure-lowering profile of omidenepag isopropyl, a selective, nonprostaglandin, prostanoid EP2 receptor agonist, in healthy Japanese and caucasian volunteers (phase I study). J. Ocul. Pharmacol. Ther. 35, 542\u2013550. https:\/\/doi.org\/10.1089\/jop.2019.0044 (2019).","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"95768_CR22","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/ijg.0000000000001221","volume":"28","author":"M Aihara","year":"2019","unstructured":"Aihara, M. et al. Phase 2, randomized, dose-finding studies of omidenepag isopropyl, a selective EP2 agonist, in patients with primary open-angle glaucoma or ocular hypertension. J. Glaucoma 28, 375\u2013385. https:\/\/doi.org\/10.1097\/ijg.0000000000001221 (2019).","journal-title":"J. Glaucoma"},{"key":"95768_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ajo.2020.06.003","volume":"220","author":"M Aihara","year":"2020","unstructured":"Aihara, M. et al. Omidenepag isopropyl versus latanoprost in primary open-angle glaucoma and ocular hypertension: the phase 3 AYAME study. Am. J. Ophthalmol. 220, 53\u201363. https:\/\/doi.org\/10.1016\/j.ajo.2020.06.003 (2020).","journal-title":"Am. J. Ophthalmol."},{"key":"95768_CR24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1146\/annurev.pharmtox.41.1.661","volume":"41","author":"RM Breyer","year":"2001","unstructured":"Breyer, R. M., Bagdassarian, C. K., Myers, S. A. & Breyer, M. D. Prostanoid receptors: Subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 41, 661\u2013690. https:\/\/doi.org\/10.1146\/annurev.pharmtox.41.1.661 (2001).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"95768_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.plefa.2004.03.021","volume":"71","author":"S Biswas","year":"2004","unstructured":"Biswas, S., Bhattacherjee, P. & Paterson, C. A. Prostaglandin E2 receptor subtypes, EP1, EP2, EP3 and EP4 in human and mouse ocular tissues\u2014a comparative immunohistochemical study. Prostaglandins Leukot. Essent. Fatty Acids 71, 277\u2013288. https:\/\/doi.org\/10.1016\/j.plefa.2004.03.021 (2004).","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"95768_CR26","first-page":"1475","volume":"43","author":"U Schlotzer-Schrehardt","year":"2002","unstructured":"Schlotzer-Schrehardt, U., Zenkel, M. & Nusing, R. M. Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues. Invest. Ophthalmol. Vis. Sci. 43, 1475\u20131487 (2002).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95768_CR27","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1089\/jop.2017.0146","volume":"34","author":"M Fuwa","year":"2018","unstructured":"Fuwa, M. et al. Effects of a novel selective EP2 receptor agonist, omidenepag isopropyl, on aqueous humor dynamics in laser-induced ocular hypertensive monkeys. J. Ocul. Pharmacol. Ther. 34, 531\u2013537. https:\/\/doi.org\/10.1089\/jop.2017.0146 (2018).","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"95768_CR28","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1167\/iovs.03-1330","volume":"45","author":"K Hirayama","year":"2004","unstructured":"Hirayama, K. et al. The involvement of the rho-kinase pathway and its regulation in cytokine-induced collagen gel contraction by hyalocytes. Invest. Ophthalmol. Vis. Sci. 45, 3896\u20133903. https:\/\/doi.org\/10.1167\/iovs.03-1330 (2004).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95768_CR29","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1167\/iovs.18-23900","volume":"59","author":"R Yamagishi-Kimura","year":"2018","unstructured":"Yamagishi-Kimura, R. et al. Interaction between pilocarpine and ripasudil on intraocular pressure, pupil diameter, and the aqueous-outflow pathway. Invest. Ophthalmol. Vis. Sci. 59, 1844\u20131854. https:\/\/doi.org\/10.1167\/iovs.18-23900 (2018).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95768_CR30","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1167\/iovs.15-17693","volume":"57","author":"G Kalouche","year":"2016","unstructured":"Kalouche, G. et al. Activation of prostaglandin FP and EP2 receptors differently modulates myofibroblast transition in a model of adult primary human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 57, 1816\u20131825. https:\/\/doi.org\/10.1167\/iovs.15-17693 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95768_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/s1350-9462(97)00003-7","volume":"17","author":"A Alm","year":"1998","unstructured":"Alm, A. Prostaglandin derivates as ocular hypotensive agents. Prog. Retin. Eye Res. 17, 291\u2013312. https:\/\/doi.org\/10.1016\/s1350-9462(97)00003-7 (1998).","journal-title":"Prog. Retin. Eye Res."},{"key":"95768_CR32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1006\/exer.1996.0224","volume":"64","author":"AH Krauss","year":"1997","unstructured":"Krauss, A. H., Wiederholt, M., Sturm, A. & Woodward, D. F. Prostaglandin effects on the contractility of bovine trabecular meshwork and ciliary muscle. Exp. Eye Res. 64, 447\u2013453. https:\/\/doi.org\/10.1006\/exer.1996.0224 (1997).","journal-title":"Exp. Eye Res."},{"key":"95768_CR33","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1167\/iovs.08-3031","volume":"50","author":"DF Woodward","year":"2009","unstructured":"Woodward, D. F. et al. Prostanoid EP4 receptor stimulation produces ocular hypotension by a mechanism that does not appear to involve uveoscleral outflow. Invest. Ophthalmol. Vis. Sci. 50, 3320\u20133328. https:\/\/doi.org\/10.1167\/iovs.08-3031 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95768_CR34","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1167\/iovs.05-1627","volume":"47","author":"SF Nilsson","year":"2006","unstructured":"Nilsson, S. F. et al. The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey. Invest. Ophthalmol. Vis. Sci. 47, 4042\u20134049. https:\/\/doi.org\/10.1167\/iovs.05-1627 (2006).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95768_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/s0014-4835(66)80019-2","volume":"5","author":"A Bill","year":"1966","unstructured":"Bill, A. Conventional and uveo-scleral drainage of aqueous humour in the cynomolgus monkey (Macaca irus) at normal and high intraocular pressures. Exp. Eye Res. 5, 45\u201354. https:\/\/doi.org\/10.1016\/s0014-4835(66)80019-2 (1966).","journal-title":"Exp. Eye Res."},{"key":"95768_CR36","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.exer.2008.01.013","volume":"86","author":"TS Acott","year":"2008","unstructured":"Acott, T. S. & Kelley, M. J. Extracellular matrix in the trabecular meshwork. Exp. Eye Res. 86, 543\u2013561. https:\/\/doi.org\/10.1016\/j.exer.2008.01.013 (2008).","journal-title":"Exp. Eye Res."},{"key":"95768_CR37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1089\/jop.2013.0220","volume":"30","author":"RJ Wordinger","year":"2014","unstructured":"Wordinger, R. J., Sharma, T. & Clark, A. F. The role of TGF-\u03b22 and bone morphogenetic proteins in the trabecular meshwork and glaucoma. J. Ocul. Pharmacol. Ther. 30, 154\u2013162. https:\/\/doi.org\/10.1089\/jop.2013.0220 (2014).","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"95768_CR38","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00441-011-1274-7","volume":"347","author":"R Fuchshofer","year":"2012","unstructured":"Fuchshofer, R. & Tamm, E. R. The role of TGF-\u03b2 in the pathogenesis of primary open-angle glaucoma. Cell Tissue Res. 347, 279\u2013290. https:\/\/doi.org\/10.1007\/s00441-011-1274-7 (2012).","journal-title":"Cell Tissue Res."},{"key":"95768_CR39","doi-asserted-by":"publisher","unstructured":"Jensen, M. S. et al. Activation of the prostaglandin E(2) EP(2) receptor attenuates renal fibrosis in unilateral ureteral obstructed mice and human kidney slices. Acta Physiol. (Oxf.) 227, e13291. https:\/\/doi.org\/10.1111\/apha.13291 (2019).","DOI":"10.1111\/apha.13291"},{"key":"95768_CR40","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1167\/iovs.05-1627","volume":"47","author":"SF Nilsson","year":"2006","unstructured":"Nilsson, S. F. et al. The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey. Invest. Ophthalmol. Vis. Sci. 47, 4042\u20134049. https:\/\/doi.org\/10.1167\/iovs.05-1627 (2006).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95768_CR41","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1242\/jcs.017897","volume":"121","author":"E Dejana","year":"2008","unstructured":"Dejana, E., Orsenigo, F. & Lampugnani, M. G. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J. Cell Sci. 121, 2115\u20132122. https:\/\/doi.org\/10.1242\/jcs.017897 (2008).","journal-title":"J. Cell Sci."},{"key":"95768_CR42","doi-asserted-by":"publisher","first-page":"402593","DOI":"10.1155\/2010\/402593","volume":"2010","author":"H Bauer","year":"2010","unstructured":"Bauer, H., Zweimueller-Mayer, J., Steinbacher, P., Lametschwandtner, A. & Bauer, H. C. The dual role of zonula occludens (ZO) proteins. J. Biomed. Biotechnol. 2010, 402593. https:\/\/doi.org\/10.1155\/2010\/402593 (2010).","journal-title":"J. Biomed. Biotechnol."},{"key":"95768_CR43","doi-asserted-by":"publisher","first-page":"4782","DOI":"10.1167\/iovs.13-12363","volume":"54","author":"JW Wang","year":"2013","unstructured":"Wang, J. W., Woodward, D. F. & Stamer, W. D. Differential effects of prostaglandin E2-sensitive receptors on contractility of human ocular cells that regulate conventional outflow. Invest. Ophthalmol. Vis. Sci. 54, 4782\u20134790. https:\/\/doi.org\/10.1167\/iovs.13-12363 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95768_CR44","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3109\/02713689508995822","volume":"14","author":"N Fujimoto","year":"1995","unstructured":"Fujimoto, N., Zhao, C. & Shichi, H. The effects of prostaglandins E2 and F2 alpha on porcine ciliary muscle cells in culture. Curr. Eye Res. 14, 1155\u20131163. https:\/\/doi.org\/10.3109\/02713689508995822 (1995).","journal-title":"Curr. Eye Res."},{"key":"95768_CR45","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1167\/iovs.16-19672","volume":"58","author":"M Montecchi-Palmer","year":"2017","unstructured":"Montecchi-Palmer, M. et al. TGF\u03b22 induces the formation of cross-linked actin networks (CLANs) in human trabecular meshwork cells through the smad and non-smad dependent pathways. Invest. Ophthalmol. Vis. Sci. 58, 1288\u20131295. https:\/\/doi.org\/10.1167\/iovs.16-19672 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95768_CR46","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1001\/archopht.119.8.1171","volume":"119","author":"M Honjo","year":"2001","unstructured":"Honjo, M. et al. Effects of protein kinase inhibitor, HA1077, on intraocular pressure and outflow facility in rabbit eyes. Arch. Ophthalmol. 119, 1171\u20131178. https:\/\/doi.org\/10.1001\/archopht.119.8.1171 (2001).","journal-title":"Arch. Ophthalmol."},{"key":"95768_CR47","doi-asserted-by":"publisher","first-page":"7097","DOI":"10.1167\/iovs.12-9989","volume":"53","author":"T Fujimoto","year":"2012","unstructured":"Fujimoto, T. et al. Involvement of RhoA\/Rho-associated kinase signal transduction pathway in dexamethasone-induced alterations in aqueous outflow. Invest. Ophthalmol. Vis. Sci. 53, 7097\u20137108. https:\/\/doi.org\/10.1167\/iovs.12-9989 (2012).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95768_CR48","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1167\/iovs.11-8018","volume":"53","author":"T Kameda","year":"2012","unstructured":"Kameda, T. et al. The effect of Rho-associated protein kinase inhibitor on monkey Schlemm\u2019s canal endothelial cells. Invest. Ophthalmol. Vis. Sci. 53, 3092\u20133103. https:\/\/doi.org\/10.1167\/iovs.11-8018 (2012).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95768_CR49","doi-asserted-by":"publisher","first-page":"C621","DOI":"10.1152\/ajpcell.00108.2003","volume":"286","author":"JA Alvarado","year":"2004","unstructured":"Alvarado, J. A., Betanzos, A., Franse-Carman, L., Chen, J. & Gonz\u00e1lez-Mariscal, L. Endothelia of Schlemm\u2019s canal and trabecular meshwork: distinct molecular, functional, and anatomic features. Am. J. Physiol. Cell Physiol. 286, C621-634. https:\/\/doi.org\/10.1152\/ajpcell.00108.2003 (2004).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"95768_CR50","doi-asserted-by":"publisher","first-page":"C330","DOI":"10.1152\/ajpcell.1999.277.2.C330","volume":"277","author":"JL Underwood","year":"1999","unstructured":"Underwood, J. L. et al. Glucocorticoids regulate transendothelial fluid flow resistance and formation of intercellular junctions. Am. J. Physiol. 277, C330-342. https:\/\/doi.org\/10.1152\/ajpcell.1999.277.2.C330 (1999).","journal-title":"Am. J. Physiol."},{"key":"95768_CR51","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.exer.2018.03.001","volume":"171","author":"KE Keller","year":"2018","unstructured":"Keller, K. E. et al. Consensus recommendations for trabecular meshwork cell isolation, characterization and culture. Exp. Eye Res. 171, 164\u2013173. https:\/\/doi.org\/10.1016\/j.exer.2018.03.001 (2018).","journal-title":"Exp. Eye Res."},{"key":"95768_CR52","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.exer.2016.07.009","volume":"158","author":"WD Stamer","year":"2017","unstructured":"Stamer, W. D. & Clark, A. F. The many faces of the trabecular meshwork cell. Exp. Eye Res. 158, 112\u2013123. https:\/\/doi.org\/10.1016\/j.exer.2016.07.009 (2017).","journal-title":"Exp. Eye Res."},{"key":"95768_CR53","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1038\/s41598-020-59941-0","volume":"10","author":"W Zhu","year":"2020","unstructured":"Zhu, W., Godwin, C. R., Cheng, L., Scheetz, T. E. & Kuehn, M. H. Transplantation of iPSC-TM stimulates division of trabecular meshwork cells in human eyes. Sci. Rep. 10, 2905. https:\/\/doi.org\/10.1038\/s41598-020-59941-0 (2020).","journal-title":"Sci. Rep."},{"key":"95768_CR54","doi-asserted-by":"publisher","first-page":"6747","DOI":"10.1167\/iovs.15-17720","volume":"56","author":"J Cai","year":"2015","unstructured":"Cai, J. et al. Expression profiling of human Schlemm\u2019s canal endothelial cells from eyes with and without glaucoma. Invest. Ophthalmol. Vis. Sci. 56, 6747\u20136753. https:\/\/doi.org\/10.1167\/iovs.15-17720 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95768_CR55","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.1167\/iovs.07-0878","volume":"48","author":"M Honjo","year":"2007","unstructured":"Honjo, M. et al. Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery. Invest. Ophthalmol. Vis. Sci. 48, 5549\u20135557. https:\/\/doi.org\/10.1167\/iovs.07-0878 (2007).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95768_CR56","first-page":"137","volume":"42","author":"M Honjo","year":"2001","unstructured":"Honjo, M. et al. Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest. Ophthalmol. Vis. Sci. 42, 137\u2013144 (2001).","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95768-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95768-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95768-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T12:21:08Z","timestamp":1670070068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95768-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,10]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["95768"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-95768-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,10]]},"assertion":[{"value":"6 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16257"}}